# Canopy Growth Corporation (CGC)

Source: https://www.quantisnow.com/company/CGC
Generated: 2026-11-22T14:52:40.128Z

- Ticker: CGC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medicinal Chemicals and Botanical Products
- SEC CIK: 0001737927
- Website: canopygrowth.com

## About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

## Latest CGC news and filings

- 2026-11-06 12:06 UTC [SEC Form 8-K] [Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/canopy-growth-corporation-filed-sec-form-8-k-results-of-operations-6777927)
- 2026-11-06 12:00 UTC [Earnings] [Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis](https://www.quantisnow.com/insight/canopy-growth-reports-second-quarter-fiscal-year-2027-financial-results-6777876)
- 2026-11-06 11:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-canopy-growth-corporation-6777856)
- 2026-10-26 11:30 UTC [Leadership Update] [Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders](https://www.quantisnow.com/insight/canopy-growth-announces-results-of-2026-annual-general-and-special-6756946)
- 2026-10-23 21:19 UTC [SEC Form 8-K] [SEC Form 8-K filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-canopy-growth-corporation-6756608)
- 2026-10-22 11:00 UTC [Earnings Date] [Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026](https://www.quantisnow.com/insight/canopy-growth-to-report-second-quarter-fiscal-2027-financial-results-6754266)
- 2026-10-16 21:02 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6749464)
- 2026-10-16 21:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-canopy-growth-corporation-6749451)
- 2026-10-13 11:30 UTC [Leadership Update] [Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower](https://www.quantisnow.com/insight/canopy-growths-smiths-falls-facility-becomes-canadas-only-eu-gmp-certified-6744116)
- 2026-10-06 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6738999)
- 2026-09-30 20:32 UTC [SEC Form 4] [Director Yanofsky Theresa sold $13,828 worth of shares (14,920 units at $0.93), decreasing direct ownership by 10% to 131,495 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/director-yanofsky-theresa-sold-13828-worth-of-shares-14920-units-6730802)
- 2026-09-30 20:31 UTC [SEC Form 4] [Director Lazzarato David Angelo sold $20,742 worth of shares (22,380 units at $0.93), decreasing direct ownership by 11% to 189,479 units (SEC Form 4) to satisfy tax liability](https://www.quantisnow.com/insight/director-lazzarato-david-angelo-sold-20742-worth-of-shares-22380-6730793)
- 2026-09-30 20:30 UTC [SEC Form 4] [Director Bayern Joseph sold $2,869 worth of shares (3,096 units at $0.93), decreasing direct ownership by 2% to 142,031 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/director-bayern-joseph-sold-2869-worth-of-shares-3096-units-6730788)
- 2026-09-30 20:30 UTC [SEC Form 4] [Director Atkins M Shan sold $2,869 worth of shares (3,096 units at $0.93), decreasing direct ownership by 2% to 143,421 units (SEC Form 4) (for withholding tax)](https://www.quantisnow.com/insight/director-atkins-m-shan-sold-2869-worth-of-shares-3096-6730766)
- 2026-09-28 11:30 UTC [Leadership Update] [Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany](https://www.quantisnow.com/insight/canopy-growth-appoints-sebastian-blte-as-country-manager-for-germany-6727085)
- 2026-09-25 18:08 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6726292)
- 2026-09-25 18:00 UTC [Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum](https://www.quantisnow.com/insight/canopy-growth-announces-adjournment-of-2026-annual-general-and-special-6726290)
- 2026-09-23 11:30 UTC [Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting](https://www.quantisnow.com/insight/canopy-growth-announces-extension-of-proxy-voting-deadline-for-2026-6723599)
- 2026-09-22 11:30 UTC [Canopy Growth Expands European Medical Cannabis Supply Into the UK](https://www.quantisnow.com/insight/canopy-growth-expands-european-medical-cannabis-supply-into-the-uk-6722344)
- 2026-09-17 22:44 UTC [SEC Form 4] [Officer Stewart Thomas Carlton sold $23,952 worth of shares (25,755 units at $0.93), decreasing direct ownership by 4% to 588,412 units (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/officer-stewart-thomas-carlton-sold-23952-worth-of-shares-25755-6719777)
- 2026-09-15 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6716154)
- 2026-09-14 11:30 UTC [Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline](https://www.quantisnow.com/insight/canopy-growth-reminds-shareholders-to-vote-ahead-of-september-23-6713711)
- 2026-09-08 11:30 UTC [Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations](https://www.quantisnow.com/insight/canopy-growth-broadens-australian-medical-cannabis-portfolio-with-new-formats-6707450)
- 2026-08-25 21:41 UTC [SEC Form 4] [Officer Gedeon Christelle sold $19,616 worth of shares (13,344 units at $1.47), decreasing direct ownership by 2% to 692,162 units (SEC Form 4) to cover taxes](https://www.quantisnow.com/insight/officer-gedeon-christelle-sold-19616-worth-of-shares-13344-units-6694669)
- 2026-08-25 21:40 UTC [SEC Form 4] [Officer Stewart Thomas Carlton sold $3,280 worth of shares (2,231 units at $1.47), decreasing direct ownership by 0.36% to 614,167 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/officer-stewart-thomas-carlton-sold-3280-worth-of-shares-2231-6694666)
- 2026-08-17 21:26 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6685436)
- 2026-08-17 11:30 UTC [Leadership Update] [Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now](https://www.quantisnow.com/insight/canopy-growth-announces-mailing-of-proxy-materials-for-2026-annual-6684216)
- 2026-08-14 20:52 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6683492)
- 2026-08-14 11:30 UTC [Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows](https://www.quantisnow.com/insight/canopy-growth-secures-renewed-eu-gmp-certification-at-kincardine-as-6681810)
- 2026-08-07 20:53 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-canopy-growth-corporation-6671996)
- 2026-08-07 20:50 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-canopy-growth-corporation-6671988)
- 2026-08-07 20:05 UTC [SEC Form 8-K] [Canopy Growth Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/canopy-growth-corporation-filed-sec-form-8-k-changes-in-registrants-6671466)
- 2026-08-07 11:05 UTC [SEC Form 8-K] [Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/canopy-growth-corporation-filed-sec-form-8-k-results-of-operations-6670536)
- 2026-08-07 11:00 UTC [Earnings] [Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses](https://www.quantisnow.com/insight/canopy-growth-reports-first-quarter-fiscal-year-2027-financial-results-6670489)
- 2026-08-07 10:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-canopy-growth-corporation-6670466)
- 2026-07-24 11:30 UTC [Earnings Date] [Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026](https://www.quantisnow.com/insight/canopy-growth-to-report-first-quarter-fiscal-2027-financial-results-6647876)
- 2026-07-21 11:30 UTC [Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference](https://www.quantisnow.com/insight/canopy-growth-announces-participation-at-upcoming-canaccord-genuity-growth-conference-6643175)
- 2026-07-17 20:25 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Canopy Growth Corporation](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-canopy-growth-corporation-6641171)
- 2026-06-29 20:16 UTC [SEC Form 4] [Director Bayern Joseph sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 145,127 units (SEC Form 4) (withholding tax)](https://www.quantisnow.com/insight/director-bayern-joseph-sold-2953-worth-of-shares-3197-units-6619041)
- 2026-06-29 20:16 UTC [SEC Form 4] [Director Yanofsky Theresa sold $13,905 worth of shares (15,054 units at $0.92), decreasing direct ownership by 9% to 146,415 units (SEC Form 4) (withholding obligation)](https://www.quantisnow.com/insight/director-yanofsky-theresa-sold-13905-worth-of-shares-15054-units-6619039)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CGC
- Earnings history: https://www.quantisnow.com/earnings/CGC
- Dividend history: https://www.quantisnow.com/dividends/CGC
- Insider transactions: https://www.quantisnow.com/insiders/CGC
- Options chain: https://www.quantisnow.com/options/CGC
- SEC 8-K filings only: https://www.quantisnow.com/company/CGC/8-k
- RSS and alerts for CGC: https://www.quantisnow.com/docs/rss-feeds.md
